• 1
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498504.
  • 2
    Chang L, Toner BB, Fukudo S et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 143546.
  • 3
    Russo MW, Gaynes BN, Drossman DA. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 1999; 29: 33943.
  • 4
    Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 137790.
  • 5
    Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 146679.
  • 6
    Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 2008; 57: 166673.
  • 7
    Aro P, Talley NJ, Ronkainen J et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009; 137: 94100.
  • 8
    Tatsuta M, Iishi H. Effect of treatment with liu-jun-zi-tang (TJ43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993; 7: 45962.
  • 9
    Naito T, Itoh H, Yasunaga F, Takeyama M. Rikkunshito raises levels of somatostatin and gastrin in human plasma. Biol Pharm Bull 2001; 24: 8413.
  • 10
    Takeda H, Sadakane C, Hattori T et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 200413.
  • 11
    Carr MN, Bekku N, Yoshimura H. Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice. Eur J Pharmacol 2006; 531: 1605.
  • 12
    Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine 2010; 17: 397403.
  • 13
    Naito T, Itoh H, Takeyama M. Some gastrointestinal function regulatory kampo medicines have modulatory effects on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure. Biol Pharm Bull 2003; 26: 1014.
  • 14
    Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gut tract. Dig Dis Sci 1997; 42: 22341.
  • 15
    Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 48: 207.
  • 16
    Von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994; 35: 53641.
  • 17
    Von der Ohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil 1994; 6: 21322.
  • 18
    Suzuki H, Watanabe S, Hamaguchi T et al. Brain activation correlates with changes in heart rate and autonomic function during rectal distention. Psychosom Med 2009; 71: 61926.
  • 19
    Talley NJ, Nyren O, Drossman DA et al. Optimal design of treatment trials In: DrossmanDA, RichterJE, TalleyNJ, ThompsonWG, CorazziariE, WhiteheadWE, eds. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment. A Multinational Consensus. Boston, USA: Little Brown, 1994: 265310.
  • 20
    Sagami Y, Shimada Y, Tayama J et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004; 53: 95864.
  • 21
    Basbaum AI, Jessell TM. The perception of pain In: KandelER, SchwartzJH, JesselTM, eds. Principles of Neural Science, 4th edn. New York: McGraw-Hill, 2000: 47291.
  • 22
    Vandenberghe J, Dupont P, Fischler B, Persoons P, Tack J. Regional brain activation during proximal stomach distention in man: a PET study. Gastroenterology 2005; 128: 56473.
  • 23
    Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006; 131: 192542.
  • 24
    Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 52635.
  • 25
    Hayakawa T, Arakawa T, Kase Y et al. Liu-jun-zi-tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res 1999; 25: 2118.
  • 26
    Suzuki H, Inadomi JM, Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21: 68896.
  • 27
    Kido T, Nakai Y, Kase Y et al. Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci 2005; 98: 1617.
  • 28
    Fukudo S, Suzuki J. Colonic motility, autonomic function, and gut hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987; 151: 37385.
  • 29
    Elsenbruch S, Lovallo WR, Orr WC. Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome. Psychosom Med 2001; 63: 80513.
  • 30
    Mon-Williams M, Wann JP, Rushton S. Binocular vision in a virtual world: visual deficits following the wearing of a head-mounted display. Ophthalmic Physiol Opt 1993; 13: 38791.
  • 31
    Mon-Williams M, Plooy A, Burgess-Limerick R, Wann J. Gaze angle: a possible mechanism of visual stress in virtual reality headsets. Ergonomics 1998; 41: 2805.
  • 32
    Delvaux MM. Stress and visceral perception. Can J Gastroenterol 1999; 13(Suppl A): 326.
  • 33
    Stengel A, Taché Y. Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 2009; 71: 21939.
  • 34
    Hveem K, Hausken T, Svebak S, Berstad A. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride. Scand J Gastroenterol 1996; 31: 4527.
  • 35
    Lunding JA, Gilja OH, Hausken T, Bayati A, Mattsson H, Berstad A. Distension-induced gastric accommodation in functional dyspepsia: effect of autonomic manipulation. Neurogastroenterol Motil 2007; 19: 36575.
  • 36
    Geeraerts B, Vandenberghe J, Van Oudenhove L et al. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology 2005; 129: 143744.
  • 37
    Tack J, Masclee A, Heading R et al. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil 2009; 21: 27280.
  • 38
    Fujitsuka N, Asakawa A, Hayashi M et al. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry 2009; 65: 74859.